84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01687517 (ClinicalTrials.gov) | October 2012 | 14/9/2012 | Efficacy and Safety of Influenza Vaccine During Sarcoidosis | Determination of the Efficacy and Safety of the Seasonal Influenza Vaccine Among Patients Suffering From Sarcoidosis. | Sarcoidosis;Influenza Vaccine | Drug: Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 18 Years | 65 Years | Both | 190 | Phase 3 | France |
| 2 | JPRN-UMIN000008813 | 2012/01/01 | 01/09/2012 | Efficacy of antibiotic prophylaxis on postbronchoscopy fever after endobronchial ultrasound-guided transbronchial needle biopsy | Efficacy of antibiotic prophylaxis on postbronchoscopy fever after endobronchial ultrasound-guided transbronchial needle biopsy - Antibiotic prophylaxis after EBUS-TBNA | primary lung cancer, sarcoidosis, malignant lymphoma, metastatic lung tumor,mediastinal tumor, etc. | AMPC/CVA+ABPC/SBT. Control. | Respiratory medicine, Juntendo university. | NULL | Complete: follow-up complete | 20years-old | 85years-old | Male and Female | 500 | Not selected | Japan |